Matches in Wikidata for { <http://www.wikidata.org/entity/Q37806190> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q37806190 description "article científic" @default.
- Q37806190 description "article scientifique" @default.
- Q37806190 description "articolo scientifico" @default.
- Q37806190 description "artigo científico" @default.
- Q37806190 description "artículu científicu espublizáu en 2010" @default.
- Q37806190 description "bilimsel makale" @default.
- Q37806190 description "scientific article published on January 2010" @default.
- Q37806190 description "vedecký článok" @default.
- Q37806190 description "vetenskaplig artikel" @default.
- Q37806190 description "videnskabelig artikel" @default.
- Q37806190 description "vědecký článek" @default.
- Q37806190 description "wetenschappelijk artikel" @default.
- Q37806190 description "wissenschaftlicher Artikel" @default.
- Q37806190 description "наукова стаття, опублікована в січні 2010" @default.
- Q37806190 description "научни чланак" @default.
- Q37806190 description "مقالة علمية نشرت في يناير 2010" @default.
- Q37806190 name "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 name "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 name "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa" @default.
- Q37806190 type Item @default.
- Q37806190 label "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 label "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 label "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa" @default.
- Q37806190 prefLabel "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 prefLabel "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 prefLabel "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa" @default.
- Q37806190 P1433 Q37806190-E0C545BE-61ED-426D-A8A1-2C28BB38A35C @default.
- Q37806190 P1476 Q37806190-2D9CFC76-8A67-4E01-B704-BE62502B429B @default.
- Q37806190 P2093 Q37806190-3FDC9012-CA49-4EB6-937C-97F639A3E3CF @default.
- Q37806190 P2093 Q37806190-E9C6F0B2-75D4-43A0-9DE2-73A5793BA83B @default.
- Q37806190 P2093 Q37806190-F0F29179-962A-43E6-96BE-D3201053C227 @default.
- Q37806190 P2860 Q37806190-A8BD81E2-4F4F-43E6-B212-ADD83F9042A9 @default.
- Q37806190 P2860 Q37806190-B5365B49-4565-401A-B979-C027196DED0F @default.
- Q37806190 P2888 Q37806190-3B4CC65C-6BD3-4126-807D-53D8CED4E4AE @default.
- Q37806190 P304 Q37806190-8BF1A332-9CA6-4D04-9C2C-65AD1344ECAF @default.
- Q37806190 P31 Q37806190-6A23F9B9-7BBD-43C5-BAA5-5C999B573EFA @default.
- Q37806190 P356 Q37806190-2444AD60-098E-43B9-8093-B294E9F37ECA @default.
- Q37806190 P433 Q37806190-73EB19B0-6CB3-4431-A51F-D27F26DFC96A @default.
- Q37806190 P478 Q37806190-D5C59654-6D96-4078-9071-634DEBFA27AD @default.
- Q37806190 P50 Q37806190-1C06B653-07A1-48F3-A80F-DE6EAB4CBA4E @default.
- Q37806190 P577 Q37806190-90B69774-762D-49C0-88C1-BFBD62689A75 @default.
- Q37806190 P5875 Q37806190-C3BF3127-1420-48FA-810B-B8A184FD575A @default.
- Q37806190 P6179 Q37806190-51E89167-E658-4B7F-B4DE-DF2638889E9B @default.
- Q37806190 P698 Q37806190-88AF7C47-9C58-490B-9D1D-553B9C8182F6 @default.
- Q37806190 P921 Q37806190-A47FFD97-A288-4927-A133-AD1D4C03394E @default.
- Q37806190 P921 Q37806190-A50301B0-7147-4F21-9878-13E2511E8596 @default.
- Q37806190 P356 11531160-000000000-00000 @default.
- Q37806190 P698 21043539 @default.
- Q37806190 P1433 Q15764758 @default.
- Q37806190 P1476 "Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden" @default.
- Q37806190 P2093 "Birgit Gradl" @default.
- Q37806190 P2093 "Ulf Persson" @default.
- Q37806190 P2093 "York Zoellner" @default.
- Q37806190 P2860 Q34554465 @default.
- Q37806190 P2860 Q39942155 @default.
- Q37806190 P2888 11531160-000000000-00000 @default.
- Q37806190 P304 "377-386" @default.
- Q37806190 P31 Q13442814 @default.
- Q37806190 P356 "10.2165/11531160-000000000-00000" @default.
- Q37806190 P433 "6" @default.
- Q37806190 P478 "8" @default.
- Q37806190 P50 Q37828502 @default.
- Q37806190 P577 "2010-01-01T00:00:00Z" @default.
- Q37806190 P5875 "47659554" @default.
- Q37806190 P6179 "1002078477" @default.
- Q37806190 P698 "21043539" @default.
- Q37806190 P921 Q300989 @default.
- Q37806190 P921 Q34 @default.